RAB39B: A novel biomarker for acute myeloid leukemia identified via multi-omics and functional validation
The objective of this research was to investigate the involvement of RAB39B in acute myeloid leukemia (AML) using bioinformatics analysis and in vitro experiments for validation.
Saved in:
| Main Authors: | Chen Shuo, Li Mengxing, Wang Jishi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-03-01
|
| Series: | Open Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/med-2025-1168 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of RAB GTPases in predicting prognosis and therapy response in pancreatic cancer
by: Jiayi Wang, et al.
Published: (2025-07-01) -
NAP1L5 in acute myeloid leukemia: a prognostic biomarker and potential therapeutic target
by: Meng Wang, et al.
Published: (2025-07-01) -
Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value
by: Yang Song, et al.
Published: (2025-06-01) -
Clinical characteristics and prognostic significance of extramedullary involvement in childhood acute myeloid leukemia
by: A. K. Ignatova, et al.
Published: (2021-04-01) -
A Novel Prognostic Risk‐Scoring Model Based on RAS Gene‐Associated Cluster in Pediatric Acute Myeloid Leukemia
by: Cai‐Ju Luo, et al.
Published: (2025-03-01)